Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

for
Venous Thromboembolism, Cancer
Location: Halifax, Levis, Greenfield Park, Montreal, Ottawa,
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT05029063

Phase 3, Recruiting

Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

for
Unspecified Adult Solid Tumor, Protocol Specific
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT00004063

Phase 1, Phase 2, Recruiting

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

for
Advanced HR+/HER2- Breast Cancer,
Location: Toronto, Atlanta GA, Nashville TN, San Antonio TX
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07288359

Phase 1, Phase 2, Recruiting

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

for
Hodgkin's Disease, Non-Hodgkin's Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT01555892

Phase 1, Recruiting

My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life

for
Cancer, Anxiety, Depressive Symptoms
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05369429

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

for
Oligometastasis, Metastatic Cancer
Location: Raleigh NC, Cary NC, Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT04085029

Recruiting

Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients

for
Lymphoproliferative Disorders
Location: Montreal, Winnipeg, Vancouver
Sponsor: St. Justine's Hospital

Sex: All

Age: 0 - 21

Code: NCT02505789

Recruiting

Rehabilitation Outcomes Study

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06674889

Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

for
Refractory Solid Tumors, Relapsed Solid Tumors,
Location: Boston MA, Philadelphia PA, Houston TX,
Sponsor: Theodore Laetsch

Sex: All

Age: 1 - 30

Code: NCT06721689

Phase 1, Phase 2, Recruiting

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

for
B-cell Malignancy, Relapsed Cancer, Refractory Cancer,
Location: New York NY, Philadelphia PA, Rochester NY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06634589

Phase 1, Phase 2, Recruiting

Inherited CAncer REgistry

for
Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT03231891

Recruiting

Epcoritamab in Previously Treated WM

for
Waldenstrom Macroglobulinemia,
Location: Boston MA, Chapel Hill NC
Sponsor: Gottfried von Keudell, MD PhD

Sex: All

Age: 18+

Code: NCT06510491

Phase 2, Recruiting

Observational Pharmaco-Epidemiology Research & Analysis

for
Chronic Disease, HIV/AIDS, Liver Diseases,
Location: Durham NC
Sponsor: Epividian

Sex: All

Age: 0+

Code: NCT03813862

Recruiting

Definitive Therapy for Oligometastatic Solid Malignancies

for
Stage IV or Recurrent Carcinoma or Sarcoma
Location: Aurora CO, Thornton CO, Littleton CO, Boulder CO
Sponsor: Rocky Mountain Cancer Centers

Sex: All

Age: 18+

Code: NCT01898962

Phase 2, Recruiting

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

for
High-grade Glioma, Solid Tumor, Unspecified, Child
Location: Edison NJ, Miami FL, Little Rock AR
Sponsor: Laminar Pharmaceuticals

Sex: All

Age: 0 - 18

Code: NCT04299191

Phase 1, Phase 2, Recruiting

Training Nurses in Basic Hypnoanalgesia Techniques

for
Cancer
Location: Montreal
Sponsor: St. Justine's Hospital

Sex: All

Age: 5 - 18

Code: NCT02421562

Recruiting

Making Healthy Habits Stick

for
Cancer, Physical Activity, Cancer Survivor, Cancer Survivorship
Location: Birmingham AL, Memphis TN
Sponsor: University of Tennessee

Sex: Female

Age: 19+

Code: NCT06745180

Recruiting

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: San Antonio TX
Sponsor: TiumBio Co., Ltd.

Sex: All

Age: 18+

Code: NCT05204862

Phase 1, Phase 2, Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Fairfax VA, Pittsburgh PA, Canton OH, Columbus OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase 1, Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial